Versameb Announces Management Update |
January 08, 2021 | January 2021 Bond Updates |
BASEL, Switzerland, Jan. 8, 2021 /PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, announces the appointment of Dr Klaas Zuideveld as Chief Executive Officer (CEO). Prof Friedrich Metzger will move back... |
View more at: https://www.prnewswire.com:443/news-releases/versameb-announces-management-update-301203287.html |
Related News |